Search results
On health policy, Biden and Trump both have records to run on — and stark contrasts
WHYY· 20 hours agoHealth care in the U.S. is undeniably expensive. This is a point that President Biden and former...
What Is the National Committee for Quality Assurance (NCQA)?
Investopedia· 1 day agoThe National Committee for Quality Assurance (NCQA) is an independent nonprofit organization that...
Thousands of kids lose Medicaid health care
Newsweek· 16 hours agoThe renewal process for Medicaid was temporarily suspended across the United States during the coronavirus pandemic, but in the last year, requirements...
Biden camp doesn’t acknowledge Trump switch on Obamacare
Politifact· 6 days agoJoe Biden has repeatedly warned voters on the campaign trail that his opponent, former President...
FAQ about Affordable Care Act Implementation Part 65
U.S. Department of Labor· 5 days agoSet out below is a Frequently Asked Question (FAQ) regarding implementation of certain provisions of the Affordable Care Act (ACA). This ...
Cash Versus Insurance: Skinny Insurance Could Save Patients Big Bucks
Arkansas Money & Politics· 2 days agoHealth insurance has been a hotly debated topic since former President Barack Obama helped pass the Affordable Care
Presidential election could decide fate of extra Obamacare subsidies
Wisconsin Examiner via Yahoo News· 4 days agoWhen Cassie Cox ended up in the emergency room in January, the Bainbridge, Georgia, resident was...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 3 days agoStarting Aug. 1, Blue...begin phasing out coverage of such weight loss drugs as Wegovy, Zepbound and...
Fact-checking Joe Biden on Black employment, health insurance and wealth
Dallas Morning News· 22 hours agoIn graduation remarks May 19 at Atlanta’s Morehouse College, a historically Black institution, Biden...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 2 days agoAffordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis ...